Back to search

United Kingdom· GB-APID-16650911000001104

MagnaPhate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution

A medicinal product containing magnesium glycerophosphate, registered in United Kingdom by Arjun Products Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedMagnaPhate (magnesium 121.25mg/5ml (5…ATC—REGISTER NO.GB-APID-1665091100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Magnesium glycerophosphate
Manufacturer
Arjun Products Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060136930126

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d2f177a5-0c76-4e9e-b4be-488a2d3b52e3
GET /v1/drugs/d2f177a5-0c76-4e9e-b4be-488a2d3b52e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "16650911000001104",
  "desc": "MagnaPhate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (Arjun Products Ltd)",
  "form": "Oral solution",
  "vpid": "16651511000001104",
  "source": "dmd",
  "vtm_id": "776614007",
  "strength": "24.25 mg",
  "substance": "Magnesium glycerophosphate",
  "ingredient": "Magnesium glycerophosphate",
  "supplier_code": "10902311000001103"
}

See everything about magnesium glycerophosphate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.